Bureau Veritas strengthens position in Canada
Bureau Veritas has acquired Maxxam to strengthen its position in Canada.
Archives for January 14, 2014
Industry applauds FDA's release of final version of liquid dietary supplements guidance
After a four-year delay, FDA has at last released a final version of its guidance on liquid dietary supplements. The document doesn’t much change the line of thinking offered in the draft version but does offer more detail and clarification and in...
Pom, Coke spat reaches Supreme Court, sparks fear over labels trumping deception claims
The US Supreme Court has agreed to hear a dispute between Pom Wonderful LLC and the Coca-Cola Co. in which Pom accuses Coke of deceptive labeling and advertising for a pomegranate blueberry juice. The case examines whether the Food, Drug and Cosmetic Act...
Truvia survey: Consumers want to manage calories, won’t give up favorite foods
A survey of American, British and French consumers by Truvia Natural Sweetener found that French consumers claim to eat the healthiest, while American and British consumers are more likely to reward themselves with food and drink. But all three consumer...
Graze.com ready to gobble up US market prospects
Snacking subscription service Graze.com has pumped nearly $5m into US expansion - a market that has very, very big potential, CEO says.
Is there room for another coconut water brand? You bet, says COCOZIA...
Is recent explosive growth in the coconut water category sustainable, and is there still room for new players as the category starts to mature?
Radio-frequency drying slashes acrylamide in potato chips: Study
Using radio-frequency to dry partially fried potato chips can limit acrylamide formation, finds research.
Ex-FDA official praises GMA call for federal GMO labeling rules, but says asking it to define ‘natural’ is a long shot
It might have enraged those in favor of mandatory GMO labeling, but a leaked document outlining the Grocery Manufacturers Association’s (GMA’s) ideas for a federally regulated 'voluntary' approach to this issue has been praised by one ex-FDA official.